Cargando…

Different mutations at position 562 of the hepatitis E virus capsid proteins exhibit differential effects on viral neutralizing activity

The hepatitis E virus (HEV) capsid protein pORF2 comprises three potential N-linked glycosylation sites. One site, N562, is located at the cell attachment and neutralizing antigenic regions. The present study performed detailed analyses of the effects of specific amino acid substitutions at position...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Mingjie, Sun, Lizhi, Wang, Yan, Gao, Shuchun, Yang, Weihua, Li, Meng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739852/
https://www.ncbi.nlm.nih.gov/pubmed/33335573
http://dx.doi.org/10.3892/etm.2020.9542
_version_ 1783623414397796352
author Xu, Mingjie
Sun, Lizhi
Wang, Yan
Gao, Shuchun
Yang, Weihua
Li, Meng
author_facet Xu, Mingjie
Sun, Lizhi
Wang, Yan
Gao, Shuchun
Yang, Weihua
Li, Meng
author_sort Xu, Mingjie
collection PubMed
description The hepatitis E virus (HEV) capsid protein pORF2 comprises three potential N-linked glycosylation sites. One site, N562, is located at the cell attachment and neutralizing antigenic regions. The present study performed detailed analyses of the effects of specific amino acid substitutions at position 562 in the homodimerization, glycosylation, antigenicity, immunogenicity and neutralization activities of HEV pORF2. Recombinant HEV pORF2 glycoprotein E1 (amino acids 439-617) and three mutant variants (N562L, N562C and N562K) were expressed in Pichia pastoris (P. pastoris) and SDS-PAGE, Western blot analysis, tunicamycin assay, double-antibody sandwich ELISA and in vitro PCR-based neutralization assay were performed to characterize the different constructs. All proteins were indicated to be secreted by P. pastoris and formed homodimers. Tunicamycin assay revealed the glycosylated status of the wild-type protein, but the mutants were indicated to be non-glycosylated. All proteins were immunoreactive with a neutralizing monoclonal antibody but were not recognized by the antibody after denaturation into monomers. An in vitro PCR-based neutralization assay using mouse antibodies indicated efficient neutralization against N562L, whereas antibodies against N562C and N562K were revealed to be non-neutralizing. Collectively, the present study indicated that specific amino acid substitutions at position 562 serve crucial roles in the activity of the HEV neutralizing epitope.
format Online
Article
Text
id pubmed-7739852
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-77398522020-12-16 Different mutations at position 562 of the hepatitis E virus capsid proteins exhibit differential effects on viral neutralizing activity Xu, Mingjie Sun, Lizhi Wang, Yan Gao, Shuchun Yang, Weihua Li, Meng Exp Ther Med Articles The hepatitis E virus (HEV) capsid protein pORF2 comprises three potential N-linked glycosylation sites. One site, N562, is located at the cell attachment and neutralizing antigenic regions. The present study performed detailed analyses of the effects of specific amino acid substitutions at position 562 in the homodimerization, glycosylation, antigenicity, immunogenicity and neutralization activities of HEV pORF2. Recombinant HEV pORF2 glycoprotein E1 (amino acids 439-617) and three mutant variants (N562L, N562C and N562K) were expressed in Pichia pastoris (P. pastoris) and SDS-PAGE, Western blot analysis, tunicamycin assay, double-antibody sandwich ELISA and in vitro PCR-based neutralization assay were performed to characterize the different constructs. All proteins were indicated to be secreted by P. pastoris and formed homodimers. Tunicamycin assay revealed the glycosylated status of the wild-type protein, but the mutants were indicated to be non-glycosylated. All proteins were immunoreactive with a neutralizing monoclonal antibody but were not recognized by the antibody after denaturation into monomers. An in vitro PCR-based neutralization assay using mouse antibodies indicated efficient neutralization against N562L, whereas antibodies against N562C and N562K were revealed to be non-neutralizing. Collectively, the present study indicated that specific amino acid substitutions at position 562 serve crucial roles in the activity of the HEV neutralizing epitope. D.A. Spandidos 2021-02 2020-11-27 /pmc/articles/PMC7739852/ /pubmed/33335573 http://dx.doi.org/10.3892/etm.2020.9542 Text en Copyright: © Xu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Xu, Mingjie
Sun, Lizhi
Wang, Yan
Gao, Shuchun
Yang, Weihua
Li, Meng
Different mutations at position 562 of the hepatitis E virus capsid proteins exhibit differential effects on viral neutralizing activity
title Different mutations at position 562 of the hepatitis E virus capsid proteins exhibit differential effects on viral neutralizing activity
title_full Different mutations at position 562 of the hepatitis E virus capsid proteins exhibit differential effects on viral neutralizing activity
title_fullStr Different mutations at position 562 of the hepatitis E virus capsid proteins exhibit differential effects on viral neutralizing activity
title_full_unstemmed Different mutations at position 562 of the hepatitis E virus capsid proteins exhibit differential effects on viral neutralizing activity
title_short Different mutations at position 562 of the hepatitis E virus capsid proteins exhibit differential effects on viral neutralizing activity
title_sort different mutations at position 562 of the hepatitis e virus capsid proteins exhibit differential effects on viral neutralizing activity
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7739852/
https://www.ncbi.nlm.nih.gov/pubmed/33335573
http://dx.doi.org/10.3892/etm.2020.9542
work_keys_str_mv AT xumingjie differentmutationsatposition562ofthehepatitiseviruscapsidproteinsexhibitdifferentialeffectsonviralneutralizingactivity
AT sunlizhi differentmutationsatposition562ofthehepatitiseviruscapsidproteinsexhibitdifferentialeffectsonviralneutralizingactivity
AT wangyan differentmutationsatposition562ofthehepatitiseviruscapsidproteinsexhibitdifferentialeffectsonviralneutralizingactivity
AT gaoshuchun differentmutationsatposition562ofthehepatitiseviruscapsidproteinsexhibitdifferentialeffectsonviralneutralizingactivity
AT yangweihua differentmutationsatposition562ofthehepatitiseviruscapsidproteinsexhibitdifferentialeffectsonviralneutralizingactivity
AT limeng differentmutationsatposition562ofthehepatitiseviruscapsidproteinsexhibitdifferentialeffectsonviralneutralizingactivity